Seeking Alpha

Seeking Alpha Portfolio App for iPad

Tro Kalayjian

Tro Kalayjian picture

Profile

Send Message

View as an RSS Feed

View Tro Kalayjian's Articles BY TICKER:

Depomed Plunges After Serada Results: Still An Attractive Buying Opportunity
on Sun, Oct 16, 2011 • PFE, BNVI.PK, DEPO • 13 Comments
Platform and Specialty Pharmaceutical Companies Could Strengthen in Face of Big Pharma's Patent Cliff
on Fri, May 27, 2011 • DEPO, VVUS, SNTS • 19 Comments
Strategies and Outlook for Xenoport's Upcoming FDA PDUFA Date
on Wed, Mar 30, 2011 • XNPT, GSK • 15 Comments
Despite Abbott Parting With Gralise, Depomed's Future Looks Bright
on Wed, Mar 23, 2011 • DEPO, ABT, PFE • 12 Comments
Pharmaceutical Companies Reformulate Pain Products: How Investors Can Benefit
on Tue, Mar 1, 2011 • PFE, KG, DRRX • 16 Comments
Bionovo Completes Financing, Announces Plan of Action: Is the Worst Over?
on Thu, Feb 24, 2011 • BNVI.PK • 20 Comments
FDA Setbacks Make Vivus a Buying Opportunity
on Wed, Feb 23, 2011 • VVUS • 25 Comments
Depomed: Attractive and Under-Appreciated Potential
on Mon, Feb 14, 2011 • DEPO • 6 Comments
Depomed's Stock Price Is a Gift Following FDA Approval of Pain Drug
on Sun, Jan 30, 2011 • DEPO, ABT, PFE • 9 Comments
Sales Potential and Chances of FDA Approval for DepoMed's DM-1796
on Fri, Jan 28, 2011 • DEPO, ABT, XNPT • 15 Comments
Finding Opportunity in Abbott - Depomed Dispute
on Thu, Jan 20, 2011 • DEPO, ABT • 7 Comments
News Stories Miss the Point as Depomed Approaches FDA Target Date
on Tue, Jan 4, 2011 • DEPO, XNPT, ABT • 72 Comments
Investment Opportunities in Women's Health
on Fri, Jun 4, 2010 • PFE, DEPO, WYE • 3 Comments
Bionovo: Challenges Ahead, But Poised to Move Higher
on Mon, Nov 9, 2009 • BNVI.PK, TEVA, WCRX • 1 Comment
Serada Half Price Sale: DepoMed's Stock Price Poised to Climb
on Sun, Nov 8, 2009 • DEPO • 3 Comments
Women's Health: After WHI, What's the Potential Market Size?
on Thu, Jul 2, 2009 • PFE, WYE, NOVN • 2 Comments
Tylenol Ban Will Hurt Several Drug Manufacturers' Bottom Lines
on Tue, Jun 30, 2009 • NVS, JNJ, PG • 4 Comments
Santarus: Business Fundamentals Are Unchanged
on Wed, Jun 24, 2009 • SNTS, DEPO, XNPT • Comment!
DepoMed: Protected by Cash and Headed Higher
on Wed, Jun 24, 2009 • DEPO • 1 Comment